NEU neuren pharmaceuticals limited

Ann: Rett Syndrome NDA accepted for Priority Review by FDA, page-111

  1. 5,945 Posts.
    lightbulb Created with Sketch. 396
    Purdue and Oxycontin is a true example of a scenario of major failure with the FDA.
    But Purdue falsely said it was a non addictive alternative to addictive opiods. And marketed the hell out of it. Lying ****s!

    Yet the FDA approved the drug after their approval process.
    Knowingly or niavely, and were very very sloooow in any push back when mounting evidence showed it was creating a disaster of addiction.

    Re: Retts - Currently there is no approved treatment for Retts, nor one likely for quite some time.
    It is not a replacement or competitor drug treatment. It will be the only treatment, IF approved.

    The only decisions the FDA need to make are:

    Does it give benefit to the sufferers?

    Do the positives outweigh the negatives?

    Does the treatment do harm to the sufferers?

    .

    I am not the FDA.
    But from all info I have seen, the answers to those questions should be:

    Yes
    Yes
    No

    .
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.04
Change
-0.500(3.99%)
Mkt cap ! $1.559B
Open High Low Value Volume
$12.45 $12.45 $11.88 $1.226M 101.9K

Buyers (Bids)

No. Vol. Price($)
4 121 $12.02
 

Sellers (Offers)

Price($) Vol. No.
$12.04 507 3
View Market Depth
Last trade - 10.28am 23/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.